e-learning
resources
Munich 2014
Tuesday, 09.09.2014
Mechanisms of COPD and inhalation injury
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Evaluation of vitamin D levels in COPD and its correlation with disease severity and frequency of exacerbations
B. Menon, A. Mittal, G. Nima, C. Kaur, U. Mittal, V. Dogra (New Delhi, India)
Source:
International Congress 2014 – Mechanisms of COPD and inhalation injury
Session:
Mechanisms of COPD and inhalation injury
Session type:
Thematic Poster Session
Number:
3960
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Menon, A. Mittal, G. Nima, C. Kaur, U. Mittal, V. Dogra (New Delhi, India). Evaluation of vitamin D levels in COPD and its correlation with disease severity and frequency of exacerbations. Eur Respir J 2014; 44: Suppl. 58, 3960
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Breathlessness perception in COPD: Relationship with exacerbation frequency
Source: International Congress 2015 – Multidimensional analysis of respiratory problems
Year: 2015
Chronic obstructive lung disease and vitamin D status: Relationship with lung function, inflammatory status and exacerbations
Source: International Congress 2015 – Monitoring airway diseases with lung function tests
Year: 2015
Malanoyl dialdehyde (MDA) and hs-CRP: How are they linked to COPD?
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
Activin-A expression in COPD exacerbations: Local index of airway inflammation? Preliminary results
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Frequency and severity of exacerbations reflect COPD severity, but not COPD phenotype as determined by quantitative CT
Source: International Congress 2014 – Markers
Year: 2014
Biomarkers in COPD exacerbation, the role of adiponectin
Source: International Congress 2014 – Predictors
Year: 2014
Agreement of severity stages and exacerbations building the new COPD risk groups
Source: Annual Congress 2013 –Respiratory and cardiovascular abnormalities in COPD: the role of exercise, nutritional status and inflammation
Year: 2013
Features of systemic inflammation in patients with stable COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Monitoring catalase activity in COPD exacerbations
Source: International Congress 2016 – Airway biomarkers
Year: 2016
Prediction of the duration of hospitilization in acute COPD exacerbations: The AECOPD-F score
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014
BNP level in patients with COPD exacerbations
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Determinants of severity of dyspnea in COPD
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Inflammatory markers and COPD phenotypes as predictors of COPD exacerbations
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
Fibrinogen and CRP biomarkers in patients with exacerbation of COPD group C and D
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Assessment of malondialdehyde in the airways during treatment of COPD exacerbations
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
Physical status and dependence levels in patients with COPD exacerbation
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in patients with COPD
Year: 2014
Is vitamin D deficiency a risk factor for COPD exacerbations?
Source: Annual Congress 2013 –Environment and lifestyle: associations with respiratory disease
Year: 2013
Midrange-proadrenomedullin in stable state predicts severe exacerbation of COPD
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept